Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022

SELL
$63.83 - $80.0 $178,404 - $223,600
-2,795 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$74.57 - $87.19 $3,728 - $4,359
50 Added 1.82%
2,795 $242,000
Q2 2021

Aug 13, 2021

SELL
$80.5 - $88.01 $8,050 - $8,801
-100 Reduced 3.51%
2,745 $203,000
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $248,937 - $271,952
-3,302 Reduced 53.72%
2,845 $222,000
Q3 2020

Nov 16, 2020

BUY
$78.33 - $90.73 $231,151 - $267,744
2,951 Added 92.33%
6,147 $494,000
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $3,672 - $4,120
-50 Reduced 1.54%
3,196 $262,000
Q1 2019

May 13, 2019

SELL
$64.48 - $81.31 $45,136 - $56,917
-700 Reduced 17.74%
3,246 $264,000
Q4 2018

Feb 13, 2019

SELL
$61.45 - $77.8 $6,145 - $7,780
-100 Reduced 2.47%
3,946 $260,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,046
4,046 $245,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track First City Capital Management, Inc. Portfolio

Follow First City Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.